Etiology and Outcome of Isolated Fetal Ascites: A Systematic Review.


Journal

Obstetrics and gynecology
ISSN: 1873-233X
Titre abrégé: Obstet Gynecol
Pays: United States
ID NLM: 0401101

Informations de publication

Date de publication:
01 12 2021
Historique:
received: 14 07 2021
accepted: 09 09 2021
pubmed: 5 11 2021
medline: 8 1 2022
entrez: 4 11 2021
Statut: ppublish

Résumé

To describe the etiology of isolated fetal ascites and associated perinatal outcomes, and to assess the progression of isolated fetal ascites to fetal hydrops. PubMed, Cochrane Library, Scopus, and ClinicalTrials.gov databases were searched using the following keywords: "fetus" OR "foetal" OR "fetal" OR "foetus" AND "ascites" from inception to February 2020. The search was limited to the English language. A total of 1,983 articles were identified through the search strategy. All studies containing five or more cases of isolated fetal ascites were included. Eleven studies, involving 315 cases of isolated fetal ascites, were eligible for inclusion in this systematic review. All included studies were evaluated using the tool for evaluating the methodologic quality of case reports and case series described by Murad et al. Data were summarized using narrative review and descriptive statistics. Two-tailed Fisher exact P values calculated from hypergeometric distribution were used to compare outcome by etiology. CIs were calculated with Clopper-Pearson exact binomial interval. The etiologies of isolated fetal ascites are genitourinary (24%), gastrointestinal (20%), viral or bacterial infections (9%), cardiac (9%), genetic disorders not otherwise categorized (8%), chylous ascites (6%), metabolic storage disorders (3%), other structural disorders (4%), other causes (4%) and idiopathic (13%). Survival is most favorable for cases of isolated fetal ascites as a result of chylous (100%), idiopathic (90%), gastrointestinal (77%) and genitourinary (77%) etiologies. Survival is least favorable for fetuses with isolated fetal ascites as a result of structural disorders (25%), cardiac etiology (32%) and metabolic storage disorders (33.3%). When pregnancy terminations were excluded, survival rates were similar between fetuses diagnosed at or after 24 weeks of gestation compared with those diagnosed at less than 24 weeks (74% vs 61%, P=.06). Progression of fetal ascites to fetal hydrops occurred in 6.6% (95% CI 3.6-9.6%) (17/259) of cases when pregnancies that were terminated were excluded. Isolated fetal ascites has a diverse etiology. Outcome is related to the etiology of isolated fetal ascites. In the majority of cases, fetal ascites does not progress to fetal hydrops. PROSPERO, CRD42020213930.

Identifiants

pubmed: 34735407
doi: 10.1097/AOG.0000000000004605
pii: 00006250-202112000-00014
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

897-904

Informations de copyright

Copyright © 2021 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

Financial Disclosure The authors did not report any potential conflicts of interest.

Références

Favre R, Dreux S, Dommergues M, Dumez Y, Luton D, Oury JF, et al. Nonimmune fetal ascites: a series of 79 cases. Am J Obstet Gynecol 2004;190:407–12. doi: 10.1016/j.ajog.2003.09.016
doi: 10.1016/j.ajog.2003.09.016
Boutall A, Urban MF, Stewart C. Diagnosis, etiology, and outcome of fetal ascites in a South African hospital. Int J Gynaecol Obstet 2011;115:148–52. doi: 10.1016/j.ijgo.2011.04.011
doi: 10.1016/j.ijgo.2011.04.011
El Bishry G The outcome of isolated fetal ascites. Eur J Obstet Gynecol Reprod Biol 2008;137:43–6. doi: 10.1016/j.ejogrb.2007.05.007
doi: 10.1016/j.ejogrb.2007.05.007
Catania VD, Muru A, Pellegrino M, Marco EA, Paradiso FV, Manzoni C, et al. Isolated fetal ascites, neonatal outcome in 51 cases observed in a tertiary referral center. Eur J Pediatr Surg 2017;27:102–8. doi: 10.1055/s-0036-1597269
doi: 10.1055/s-0036-1597269
Zelop C, Benacerraf BR. The causes and natural history of fetal ascites. Prenat Diagn 1994;14:941–6. doi: 10.1002/pd.1970141008
doi: 10.1002/pd.1970141008
Mueller-Heubach E, Mazer J. Sonographically documented disappearance of fetal ascites. Obstet Gynecol 1983;61:253–7.
Dreux S, Salomon LJ, Rosenblatt J, Favre R, Houfflin-Debarge V, Broussin B, et al. Biochemical analysis of ascites fluid as an aid to etiological diagnosis: a series of 100 cases of nonimmune fetal ascites. Prenat Diagn 2015;35:214–20. doi: 10.1002/pd.4522
doi: 10.1002/pd.4522
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535–12. doi: 10.1136/bmj.b2535
doi: 10.1136/bmj.b2535
Society for Maternal-Fetal Medicine, Norton ME, Chauhan SP, Dashe JS. Society for Maternal-Fetal Medicine (SMFM) clinical guideline #7: nonimmune hydrops fetalis. Am J Obstet Gynecol 2015;212:127–39. doi: 10.1016/j.ajog.2014.12.018
doi: 10.1016/j.ajog.2014.12.018
Murad MH, Sultan S, Haffar S, Bazerbachi F. Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med 2018;23:60–3. doi: 10.1136/bmjebm-2017-110853
doi: 10.1136/bmjebm-2017-110853
Shweni PM, Kambaran SR, Ramdial K. Fetal ascites. A report of 6 cases. S Afr Med J 1984;66:616–8.
Baccega F, de Lourdes Brizot M, Jornada Krebs VL, Vieira Francisco RP, Zugaib M. Nonimmune fetal ascites: identification of ultrasound findings predictive of perinatal death. J Perinat Med 2016;44:195–200. doi: 10.1515/jpm-2014-0326
doi: 10.1515/jpm-2014-0326
Mir NA, Perlman MR. Non-immune fetal ascites: an appraisal of etiology and outcome--a clinical and pathological review of 35 cases. Asia Oceania J Obstet Gynaecol 1987;13:287–92. doi: 10.1111/j.1447-0756.1987.tb00266.x
doi: 10.1111/j.1447-0756.1987.tb00266.x
Schmider A, Henrich W, Reles A, Kjos S, Dudenhausen JW. Etiology and prognosis of fetal ascites. Fetal Diagn Ther 2003;18:230–6. doi: 10.1159/000070801
doi: 10.1159/000070801
Nose S, Usui N, Soh H, Kamiyama M, Tani G, Kanagawa T, et al. The prognostic factors and the outcome of primary isolated fetal ascites. Pediatr Surg Int 2011;27:799–804. doi: 10.1007/s00383-011-2855-y
doi: 10.1007/s00383-011-2855-y
Sciard C, Collardeau-Frachon S, Atallah A, Combourieu D, Massardier J, Heissat S, et al. Prenatal imaging features suggestive of liver gestational allo immune disease. J Gynecol Obstet Hum Reprod 2019;48:61–4. doi: 10.1016/j.jogoh.2018.11.005
doi: 10.1016/j.jogoh.2018.11.005

Auteurs

Rebecca Horgan (R)

Department of Obstetrics & Gynecology, Monmouth Medical Center, Long Branch, New Jersey; the Department of Obstetrics & Gynecology, New York Medical College, Valhalla, New York; the Division of Maternal Fetal Medicine, Department of Obstetrics & Gynecology, Weill Cornell Medicine, New York, New York; the Center for Genetic Medicine Research, Children's National Medical Center, Washington, DC; the Department of Biochemistry, Robert-Debré University Hospital, APHP, Paris, France; the Departamento de Obstetrícia e Ginecologia, Hospital das Clinicas da FMUSP, São Paulo, Brazil; the Department of Obstetrics and Gynecology, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa; the Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Eastern Virginia Medical School, Norfolk, Virginia; and the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH